# US 2001/0034319 A1 · Photothermal vascular targeting with bioreductive agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0034319 A1
- Document ID: US20010034319A1
- Status: Published application
- Kind: A1
- Application number: 09/873,599
- Filed: 2001-06-04
- Published: 2001-10-25
- Earliest claimed: 1999-03-23
- Inventors: Kathleen McMillan; Frederic M. Durville
- Web page: https://patentgrep.com/patent/US20010034319A1

## CPC

- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- A61B 18/203: {applying laser energy to the outside of the body}
- A61B 2018/00452: {Skin}
- A61B 2018/00458: {Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains}
- A61N 2005/0645: {Applicators worn by the patient}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method of selectively enhancing the effect of photothermal vascular targeting on tumor regression by administration of a bioreductive agent is disclosed.

## Claims

### Claim 1

A method of treating a tumor characterized by nutrient-providing blood vessels comprising
irradiating the tumor or nutrient providing blood vessels in the presence of a bioreductive agent,
providing an environment of hypoxia for the bioreductive agent, and
allowing the bioreductive agent to act as a cytotoxic agent in a manner to reduce tumor size.
